drugset
Drugs / SCD-Omegatex™
last change Oct 2018 re-read 3 minutes ago

SCD-Omegatex™

also known as Enteric Fish Oil 250 DHA/27 EPA Soft Gelatin Capsule
Developed for
sickle cell disease
Investigated by
National Institute of General Medical Sciences (NIGMS) · Robin E. Miller · Solutex GC S.L. · Thomas Jefferson University

Trials 1

today NCT02947100 · Ph 1/2
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02947100 Jan → Oct 2018 sickle cell disease Robin E. Miller Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SCD-Omegatex ClinicalTrials.gov intervention name — accepted as the source's own label NCT02947100 ↗
Known as Enteric Fish Oil 250 DHA/27 EPA Soft Gelatin Capsule “Subjects will receive SCD-Omegatex™ (Enteric Fish Oil 250 DHA/27 EPA Soft Gelatin Capsule, 450 mg) at one of two daily doses, orally, once a day for 6 months.” NCT02947100 ↗
Route Oral “orally” NCT02947100 ↗